Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT (Tables)

v3.24.3
SHAREHOLDERS' DEFICIT (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of stock options activity

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2022

 

2,724

$

2,332.80

 

2.8

 

  

Options granted

 

556

$

15.48

Options canceled

 

(1,256)

$

2,354.76

Balance at December 31, 2023

 

2,024

$

1,683.90

3.5

Options expired

(298)

$

2,808.00

Options canceled

 

(926)

$

717.98

Balance at June 30, 2024

 

800

$

2,156.27

 

1.8

 

$

Vested and exercisable at June 30, 2024

 

791

$

2,149.81

 

1.8

 

$

Schedule of stock options outstanding and exercisable

The following table summarizes information about stock options outstanding and exercisable under the Company’s Stock Option Plan at June 30, 2024:

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

117

 

0.5

$

2,304.00

 

117

$

2,304.00

430

1.8

$

1,908.00

430

$

1,908.00

83

2.0

$

2,016.00

83

$

2,016.00

170

2.5

$

2,754.00

161

$

2,754.00

800

 

1.8

$

2,156.27

 

791

$

2,149.81

Schedule of warrants

Balance at December 31, 2023

 

10,832

Warrants expired

 

(480)

Balance at June 30, 2024

 

10,352

Debenture, warrants issued

764

Other warrants issued

500

December 2020 equity financing warrants issued

9,088

Total warrants outstanding

 

10,352